CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.
Angela Gutierrez-CaminoMaxime CaronChantal RicherClaire FuchsUnai IllarregiLucas PonceletPascal St-OngeAlain R BataillePascal Tremblay-DauphinaisElixabet Lopez-LopezMireia CamosManuel RamírezItziar AstigarragaÉric LécuyerGuillaume BourqueIdoia Martin-GuerreroDaniel SinnettPublished in: International journal of molecular sciences (2024)
Childhood B-cell acute lymphoblastic leukemia (B-ALL) is a heterogeneous disease comprising multiple molecular subgroups with subtype-specific expression profiles. Recently, a new type of ncRNA, termed circular RNA (circRNA), has emerged as a promising biomarker in cancer, but little is known about their role in childhood B-ALL. Here, through RNA-seq analysis in 105 childhood B-ALL patients comprising six genetic subtypes and seven B-cell controls from two independent cohorts we demonstrated that circRNAs properly stratified B-ALL subtypes. By differential expression analysis of each subtype vs. controls, 156 overexpressed and 134 underexpressed circRNAs were identified consistently in at least one subtype, most of them with subtype-specific expression. TCF3::PBX1 subtype was the one with the highest number of unique and overexpressed circRNAs, and the circRNA signature could effectively discriminate new patients with TCF3::PBX1 subtype from others. Our results indicated that NUDT21 , an RNA-binding protein (RBP) involved in circRNA biogenesis, may contribute to this circRNA enrichment in TCF3::PBX1 ALL. Further functional characterization using the CRISPR-Cas13d system demonstrated that circBARD1 , overexpressed in TCF3::PBX1 patients and regulated by NUDT21 , might be involved in leukemogenesis through the activation of p38 via hsa-miR-153-5p . Our results suggest that circRNAs could play a role in the pathogenesis of childhood B-ALL.
Keyphrases
- acute lymphoblastic leukemia
- rna seq
- crispr cas
- end stage renal disease
- binding protein
- childhood cancer
- ejection fraction
- newly diagnosed
- early life
- prognostic factors
- poor prognosis
- allogeneic hematopoietic stem cell transplantation
- squamous cell carcinoma
- genome editing
- dna methylation
- acute myeloid leukemia
- patient reported outcomes
- patient reported
- nucleic acid